Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

MedX Health’s Oralase Portable Laser prepares for US launch

MedX Health : 07 October, 2008  (New Product)
MedX Health’s Oralase Portable Laser has been cleared for marketing by the US FDA.
MedX's distribution partner, Technology4Medicine, a laser company in San Clemente, California, USA, will begin immediate distribution of Oralase to dental offices in the USA. Oralase is a photobiomodulation device, also known as low level laser therapy (LLLT), exclusively designed for dentists to alleviate pain and accelerate tissue repair following dental procedures.

'We are very pleased to have received the 510(k) Clearance Letter from the FDA so that we can begin to immediately provide the dental community with our non-invasive and drug free solution to relieve pain due to surgical and other procedures. Oralase will not only relieve the pain by accelerating tissue repair, but it will provide patients the increased comfort of accelerated healing,' said Steve Guillen, president and chief executive officer, MedX Health. 'Through our partnership with Technology4Medicine, we expect to fulfill a great unmet need in the dental community as well as other markets including dermatology and plastic surgery.'

'With this FDA clearance, we will offer Oralase to dentists across the US taking dentistry to a new level, increasing production for the dental office, and providing a better experience for patients,' stated Jeffrey W Jones, chief executive officer of Technology4Medicine.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo